Skip to content

    Cancer Health Center

    Font Size

    Multiple Myeloma

    Treatment continued...

    Immunotherapy is a treatment that uses antibodies to attack the cancer cells. It is usually reserved for patients who have not had success with other treatments. Daratumumab (Darzalex) and elotuzumab (Empliciti) are two antibodies that target multiple myeloma cells.

    Radiation therapy may also help you. A beam is directed from a machine to a bone or other affected part of the body. The rays kill plasma cells, helping to lessen pain and strengthen the weakened bone.

    Research is ongoing, including clinical trials to identify more effective chemotherapy drugs and combinations.

    What to Expect

    Multiple myeloma varies widely between people. Some will live for years with few symptoms. With others, the condition gets worse quickly. Identifying the forms of multiple myeloma is often challenging for doctors.

    Systems have been developed that predict survival rates. The simplest and most common uses the blood levels of two substances: albumin and beta-2-microglobulin. A higher albumin level and a lower beta-2-microglobulin level suggest a better chance for longer survival.

    Other systems use multiple lab or DNA tests in plasma cells.

    Knowing how aggressive your multiple myeloma is can help you and your doctor find the best plan for you.

    WebMD Medical Reference

    Reviewed by Melinda Ratini, DO, MS on February 16, 2016
    1 | 2 | 3

    Today on WebMD

    Colorectal cancer cells
    New! I AM Not Cancer Facebook Group
    Lung cancer xray
    See it in pictures, plus read the facts.
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Ovarian cancer illustration
    Real Cancer Perspectives
    Jennifer Goodman Linn self-portrait
    what is your cancer risk
    colorectal cancer treatment advances
    breast cancer overview slideshow
    prostate cancer overview
    lung cancer overview slideshow
    ovarian cancer overview slideshow
    Actor Michael Douglas